1. Golgi protein 73 and its diagnostic value in liver diseases
    Yanyan Xia et al, 2019, Cell Proliferation CrossRef
  2. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma
    Xiao Xu et al, 2016, Oncotarget CrossRef
  3. Development of an alpha-fetoprotein and Golgi protein 73 multiplex detection assay using xMAP technology
    Yun Wu et al, 2018, Clinica Chimica Acta CrossRef
  4. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma
    Ying Yang et al, 2017, Oncology Reports CrossRef
  5. Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta‐analysis
    Yu Zhang et al, 2020, Molecular Genetics & Genomic Medicine CrossRef
  6. Should AFP (or Any Biomarkers) Be Used for HCC Surveillance?
    Hager F. Ahmed Mohammed et al, 2017, Current Hepatology Reports CrossRef
  7. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis
    Meiyu Dai et al, 2015, PLOS ONE CrossRef
  8. GP73 promotes epithelial–mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma
    Ying Yang et al, 2018, Carcinogenesis CrossRef
  9. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73
    Jinli Zhao et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  10. A novel oncolytic adenovirus inhibits hepatocellular carcinoma growth
    Yu-huan Bai et al, 2019, Journal of Zhejiang University-SCIENCE B CrossRef
  11. Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma
    Yan Lin et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  12. Recent advances of GOLM1 in hepatocellular carcinoma
    Jiuliang Yan et al, 2020, Hepatic Oncology CrossRef
  13. Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stability
    Zhenguo Zi et al, 2023, Blood Advances CrossRef
  14. Simple and robust diagnosis of early, small and AFP-negative primary hepatic carcinomas: an integrative approach of serum fluorescence and conventional blood tests
    Ting Wang et al, 2016, Oncotarget CrossRef
  15. Hepatocellular Carcinoma
    Stacey Prenner et al, 2018, Zakim and Boyer's Hepatology CrossRef
  16. Promising biomarkers for liver cancer
    Ravikiran Tekupalli et al, 2022, Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 CrossRef
  17. Protein Biomarkers in the Management of Hepatocellular Carcinoma: Novel Combinatory Approaches
    Philip Johnson et al, 2016, Hepatocellular Carcinoma CrossRef

  18. Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma


    Omaima Mohamed Ali et al, 2020, International Journal of General Medicine CrossRef
  19. Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis
    Jinwan Li et al, 2017, Clinics and Research in Hepatology and Gastroenterology CrossRef
  20. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial–mesenchymal transition through the TGF‐β1/Smad2 signalling pathway
    Han‐Jie Yang et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
  21. High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study
    Jian Guo Shen et al, 2021, Pathology and Oncology Research CrossRef
  22. Clinical value of urinary retinol‑binding protein in ascites due to cirrhosis
    Yujing Xia et al, 2017, Experimental and Therapeutic Medicine CrossRef
  23. Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis
    Wenli Sai et al, 2015, Hepatitis Monthly CrossRef
  24. Serum Golgi protein 73 as a sensitive biomarker for early detection of hepatocellular carcinoma among Egyptian patients with hepatitis C virus-related cirrhosis
    Mohamed Eissa et al, 2021, Medical Journal Armed Forces India CrossRef
  25. Role of ssDNA as a Noninvasive Indicator for the Diagnosis and Prognosis of Hepatocellular Carcinoma: An Exploratory Study
    Qi Zhao et al, 2021, Disease Markers CrossRef